<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>大叔快评 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-10-28T16:34:50+08:00</updated>
  <subtitle>肿瘤学临床研究及制药企业研发评述</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>KRAS G12C抑制剂MRTX849和AMG510临床数据更新和比较</title>
    <updated>2020-10-26T22:18:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/veOWe9-ojoUbUnUv1xkYnw</id>
    <link href="https://mp.weixin.qq.com/s/veOWe9-ojoUbUnUv1xkYnw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药物警戒从幕后到前台，冲锋号已经吹响！</title>
    <updated>2020-10-26T22:18:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/pkYqUCBl4SDVitM9i75byQ</id>
    <link href="https://mp.weixin.qq.com/s/pkYqUCBl4SDVitM9i75byQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>真实世界数据研究用于药品及医疗器械的评价</title>
    <updated>2020-10-25T22:04:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-25:/s/zNFYzjblmg7nHUn0tf0ALw</id>
    <link href="https://mp.weixin.qq.com/s/zNFYzjblmg7nHUn0tf0ALw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【NACLC20】PD-1/PD-L1单抗治疗驱动基因阳性NSCLC的PFS差异</title>
    <updated>2020-10-25T22:04:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-25:/s/OlbCcrfsZEamOgD-WRMPtA</id>
    <link href="https://mp.weixin.qq.com/s/OlbCcrfsZEamOgD-WRMPtA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>智胜科技与医疗，共建数字化创新医疗生态圈</title>
    <updated>2020-10-23T08:41:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-23:/s/RuLpuQaqr6tyhO63MHuThg</id>
    <link href="https://mp.weixin.qq.com/s/RuLpuQaqr6tyhO63MHuThg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>钟立业教授解读 | 真实世界初治多发性骨髓瘤长程管理中PIs同类药物转换治疗可行性： US-MM6最新数据解读</title>
    <updated>2020-10-23T08:41:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-23:/s/o1E977ZYYt75s9z-l7s-Kw</id>
    <link href="https://mp.weixin.qq.com/s/o1E977ZYYt75s9z-l7s-Kw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田:维得利珠单抗（皮下注射剂型）维持治疗溃疡性结肠炎研究数据</title>
    <updated>2020-10-16T14:12:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-16:/s/-pb5VtRNKTp0IDUOaqD8ww</id>
    <link href="https://mp.weixin.qq.com/s/-pb5VtRNKTp0IDUOaqD8ww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>奥希替尼联合抗血管生成单抗治疗EGFR T790M阳性晚期NSCLC</title>
    <updated>2020-10-15T22:04:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-15:/s/TPH5rFx1DUJGyja4IRnxEQ</id>
    <link href="https://mp.weixin.qq.com/s/TPH5rFx1DUJGyja4IRnxEQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>多发性骨髓瘤患者细胞遗传学异常与疾病特征和治疗反应的相关性研究</title>
    <updated>2020-10-15T22:04:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-15:/s/18jPyPChPpXQL4DQ06NpNg</id>
    <link href="https://mp.weixin.qq.com/s/18jPyPChPpXQL4DQ06NpNg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>作为MA的您焦虑了吗？| 第五届CMAC国内药企年会圆满结束</title>
    <updated>2020-10-15T22:04:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-15:/s/SRvstNKMW96muguT1eoR8Q</id>
    <link href="https://mp.weixin.qq.com/s/SRvstNKMW96muguT1eoR8Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田下注RNAi平台:研发针对罕见病AATD新疗法</title>
    <updated>2020-10-09T22:01:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-09:/s/HZj1zjtPFH2I2Ozc7Nvc7Q</id>
    <link href="https://mp.weixin.qq.com/s/HZj1zjtPFH2I2Ozc7Nvc7Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>RNAi（干扰）技术在哺乳动物中的应用</title>
    <updated>2020-10-09T22:01:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-09:/s/FlbTcQXtv9zjliW2fs7YUw</id>
    <link href="https://mp.weixin.qq.com/s/FlbTcQXtv9zjliW2fs7YUw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>JAMA Oncology: 普那布林预防化疗引起的中性粒细胞减少症</title>
    <updated>2020-10-08T11:52:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-08:/s/FHa0xayr_T5PKogO_w0mpA</id>
    <link href="https://mp.weixin.qq.com/s/FHa0xayr_T5PKogO_w0mpA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>KRAS新药VS-6766</title>
    <updated>2020-10-08T11:52:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-08:/s/x-dcIg16Z0HosQaKJNa4Bg</id>
    <link href="https://mp.weixin.qq.com/s/x-dcIg16Z0HosQaKJNa4Bg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Opdivo非小细胞肺癌新辅助phase III研究达到主要研究终点pCR</title>
    <updated>2020-10-07T22:07:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-07:/s/ohn60VgtblTHAzVMTXjLAA</id>
    <link href="https://mp.weixin.qq.com/s/ohn60VgtblTHAzVMTXjLAA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四代EGFR抑制剂CH7233163的结构式</title>
    <updated>2020-10-06T11:23:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-06:/s/gFZukB6yGhHVAYbvFumVZg</id>
    <link href="https://mp.weixin.qq.com/s/gFZukB6yGhHVAYbvFumVZg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年国庆与中秋快乐</title>
    <updated>2020-10-01T15:11:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-01:/s/99UZjOY-cu_Sb0pfE_VXYA</id>
    <link href="https://mp.weixin.qq.com/s/99UZjOY-cu_Sb0pfE_VXYA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刘澎教授解读 | 首个关于伊沙佐米在NDMM真实世界中的研究结果重磅出炉</title>
    <updated>2020-10-01T15:11:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-01:/s/tOYnVhb3FWF5b9YH0C20fw</id>
    <link href="https://mp.weixin.qq.com/s/tOYnVhb3FWF5b9YH0C20fw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>